Yuan Ma

Title: Innovations in Asthma Treatment by Yuan Ma

Introduction

Yuan Ma is an innovative inventor based in Macau, CN. He has made significant contributions to the field of respiratory medicine, particularly in the treatment of asthma. His work focuses on the use of ganoderma fungal RNA molecules, which have shown promising results in inhibiting airway smooth muscle cell changes associated with asthma.

Latest Patents

Yuan Ma holds a patent for the "Use of ganoderma fungal RNA molecules, drug, drug composition and delivery carrier." This patent outlines a novel approach to treating asthma by utilizing tRFs derived from traditional Chinese medicine. The research indicates that these RNA molecules can effectively inhibit the proliferation and abnormal secretion of airway smooth muscle cells induced by TGF-β1. The findings suggest that this pharmaceutical composition could serve as a new medicine for asthma treatment.

Career Highlights

Yuan Ma is affiliated with the Macau University of Science and Technology, where he conducts research and development in the field of respiratory diseases. His work has been instrumental in advancing the understanding of asthma and exploring new therapeutic options.

Collaborations

Yuan Ma collaborates with notable colleagues, including Zhihong Jiang and Fei Ren. Their combined expertise contributes to the ongoing research and development of innovative treatments for respiratory conditions.

Conclusion

Yuan Ma's contributions to asthma treatment through his innovative use of ganoderma fungal RNA molecules highlight the potential for new therapeutic approaches in respiratory medicine. His work not only advances scientific knowledge but also offers hope for improved treatment options for asthma patients.